Methods for non-invasive prenatal ploidy calling
US-2024062846-A1 · Feb 22, 2024 · US
US9534251B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9534251-B2 |
| Application number | US-75057110-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 30, 2010 |
| Priority date | Aug 11, 2005 |
| Publication date | Jan 3, 2017 |
| Grant date | Jan 3, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates, e.g., to in vitro method, using isolated protein reagents, for joining two double stranded (ds) DNA molecules of interest, wherein the distal region of the first DNA molecule and the proximal region of the second DNA molecule share a region of sequence identity, comprising contacting the two DNA molecules in a reaction mixture with (a) a non-processive 5′ exonuclease; (b) a single stranded DNA binding protein (SSB) which accelerates nucleic acid annealing; (c) a non strand-displacing DNA polymerase; and (d) a ligase, under conditions effective to join the two DNA molecules to form an intact double stranded DNA molecule, in which a single copy of the region of sequence identity is retained. The method allows the joining of a number of DNA fragments, in a predetermined order and orientation, without the use of restriction enzymes.
Opening claim text (preview).
The invention claimed is: 1. A kit for in vitro joining a plurality of dsDNA molecules, consisting essentially of in a single container, a mixture of the isolated proteins (i) a single stranded DNA binding protein (SSB) which accelerates nucleic acid annealing, (ii) a non strand-displacing DNA polymerase, and (iii) a ligase; (iv) an isolated non-processive 5′ exonuclease; and (v) glycerol in an amount effective as a preservative; wherein the ratios of activities of (i), (ii), (iii), and (iv) are effective to achieve in vitro joining of dsDNA molecules, and wherein the dsDNA molecules are joined via a region of sequence homology to form a DNA molecule in which a single copy of the region of sequence homology is retained. 2. The kit of claim 1 , wherein the mixture contains (i) as the SSB, the phage T7 gene 2.5 product, the E. coli recA protein, RedB of lambda phage, or RecT of Rae prophage; (ii) as the DNA polymerase, the T7 gene 5 product, T4 polymerase, or E. coli pol; and/or (iii) as the ligase, the phage T7 gene 1.3 product, phage T4 DNA ligase, or E. coli DNA ligase; and/or (iv) as the 5′ exonuclease, the phage T7 gene 6 product, RedA of lambda phage, or RecE of Rae prophage. 3. The kit of claim 2 wherein: (i) the phage T7 gene 2.5 product, the E. coli recA protein, RedB of lambda phage, or RecT of Rae prophage are substantially purified; (ii) the T7 gene 5 product, T4 polymerase, or E. coli pol are substantially purified; and/or (iii) the phage T7 gene 1.3 product, phage T4 DNA ligase, or E. coli DNA ligase are substantially purified. 4. The kit of claim 3 wherein the non-processive 5′ exonuclease is substantially purified. 5. The kit of claim 3 further comprising instructions for performing a method for the in vitro joining of a plurality of dsDNA molecules. 6. The kit of claim 1 wherein: (i) the single stranded DNA binding protein (SSB) is substantially purified; (ii) the non strand-displacing DNA polymerase is substantially purified, and (iii) the ligase is substantially purified. 7. The kit of claim 6 wherein the non-processive 5′ exonuclease is substantially purified. 8. The kit of claim 6 further comprising instructions for performing a method for the in vitro joining of a plurality of dsDNA molecules. 9. A composition consisting essentially of: (a) a substantially purified single stranded DNA binding protein (SSB) which accelerates nucleic acid annealing, (b) a substantially purified non strand-displacing DNA polymerase, (c) a substantially purified ligase, and (d) substantially purified non-processive 5′ exonuclease, and (e) glycerol in an amount effective as a preservative; wherein the ratios of activities of (a), (b), (c) and (d) are effective to achieve in vitro joining of dsDNA molecules via a region of homology.
Exodeoxyribonuclease (lambda-induced) (3.1.11.3) · CPC title
DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase · CPC title
General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host · CPC title
General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease · CPC title
Ligase chain reaction [LCR] · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.